Navigation Links
C. difficile epidemic should concern not only hospital patients but people at home

Without proper infection prevention in hospitals, and now homes, the Clostridium difficile bacteria poses a major health threat, cautions a Case Western Reserve University infection control researcher.

While mainly a concern in hospitals, cases of the C. difficile infection (or C. diff) are on the rise in the community, according to the Centers for Disease Control and Prevention that has seen increased reports of the infected people who have had no contact with hospital patients with the infection. The CDC reported 7.6 people out of 100,000 who had no contact with people with C. diff were getting sick with the illness.

It particularly infects healthy people, and particularly pregnant women, said Irena Kenneley, a Case Western Reserve clinical nurse specialist in infection control and associate professor at the Frances Payne Bolton School of Nursing.

Symptoms of C. diff include continual bouts of diarrhea, severe cramps, swollen stomach and intestinal irritation.

Potentially, the bacteria's toxins can cause ulcers and eventually eat through intestine walls, which allows infection to enter the blood.

Kenneley's American Journal of Nursing article, "Clostridium difficile Infection Is on the Rise," focuses on evidence-based steps recommended by the CDC that nurses and other health care workers, including those who prepare and deliver food, clean facilities or make deliveries, can take to confine the bacteria in hospitals and other settings where someone shows symptoms of the infection. And similar precautions apply at home.

"The article delivers practical advice to nurses and nurse practitioners on infection prevention and control activities in any setting," Kenneley said.

Based on CDC guidelines, she recommends:

  • Isolating the patient (or, if possible, the person at home) when symptoms appear;
  • Appropriate and timely lab testing to determine the type of bacteria present;
  • Treating with appropriate antibiotics;
  • Cleaning thoroughly (using bleach is best);
  • Washing hands to stop the spread of further infections.

That last step, washing hands, is critical for hospital workers, family members and other visitors who have encountered someone with C. diff or is suspected to have contracted the bacteria. It can take up to 96 hours to confirm a C. diff diagnosis. Because of the wait for a diagnosis, isolation of the patient is keya practice similar to hospital protocol for patients with suspected tuberculosis.

Kenneley said these bacteria that can live as hibernating spores up to 100 years on surfaces until conditions are right to proliferate. The stomach and intestines offer that environment, once ingested.

Particularly at risk are people with compromised immune systems (HIV and transplant patients), those who are aging, recovering from gastrointestinal surgeries or are on antibiotics for more than three days to treat other illnesses.

C. diff has proliferated through use of broad-spectrum antibiotics that wipe out the healthy bacteria. A few antibiotics, such as vancomycin and metronidazole, have some success treating the infection, she said.

Poor hand-washing practices allow spores to travel between patients and other surfaces. Hand-washing must occur multiple times during patient care.

Kenneley recommends washing hands before entering a room, any time the hands touch a new surface in the room, and when exiting. And soap is more effective than alcohol-based hand sanitizers or wipes that do not destroy spores, she said.

Although hospitals clean rooms daily and after a patient leaves, some spores may still survive, Kenneley said, which is why the key to prevention is hand-washing.

Contact: Susan Griffith
Case Western Reserve University

Related medicine news :

1. Reporting of hospital infection rates and burden of C. difficile
2. Groundbreaking clinical trial looks at fecal transplant as treatment for C. difficile
3. Dedicated cleaning staff shown to reduce C. difficile contamination in hospital rooms
4. Rhode Island Hospital reduces incidence of hospital-associated C. difficile by 70 percent
5. Fidaxomicin in Clostridium difficile infection: added benefit not proven
6. Low dose antibiotic treatment of C-difficile as effective as high dose in hospital setting
7. Researchers find novel approach for controlling deadly C. difficile infections
8. Use of frozen material for fecal transplant successfully treats C. difficile infection
9. Sanofi Pasteur announces favorable Phase II data for investigational C. difficile vaccine
10. Canada should play a role in addressing the global cancer epidemic
11. NIH scientists link quickly spreading gene to Asian MRSA epidemic
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon ... programs, launches new Wimbledon Athletics Facebook page to educate the public, ... unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die from ...
(Date:11/25/2015)... ... 25, 2015 , ... Smiles by Stevens is pleased to announce ... wrinkling. While many patients are aware of the benefits of Botox® in the treatment ... those suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... decades of music, friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled ... 5-6. , For 65 years, Brillianteen has been a treasured tradition ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... I found that regular bras were incredibly uncomfortable," said an inventor from Bronx, ... bra." , She developed the patent-pending RECOVERY BRA for added comfort and support. ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... today that the first patient has been enrolled in ... treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... 1/2 clinical trial, ESSA intends to demonstrate the safety, ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: